Cannabis Life Science Hits the IBR Radar

It’s a remarkable time to be an investor in the marijuana industry. So many interesting companies from which to choose. We are (almost) all in agreement that it is not a question of “if” marijuana will be legalized across the globe, but when. This mindset change represents an astonishing opportunity for investors looking forward 10-20 years.

Cannabis Life Science, $CLSH – OTCQB is a company we feel merits some very serious love and attention. And so do Ray J and Snoop Dog, watch the video here.

The team behind CLS are very accomplished and equity market savvy seasoned dealmakers. Their most recently announced acquisition of Oasis Cannabis can be found here. (Oasis currently generates about 650k/month in revs)

The CLS strategy and business model will be similar to Canopy Growth, Aurora Cannabis, and GB Sciences. (much more on this in the upcoming report)

IBR is most delighted to be bring you this extraordinary opportunity before the herd starts to jump all over it in 2018.

We look forward to publishing our report and expectations for CLSH in the coming weeks.

With a market cap of only $26M or 3X 2017 revs (approx), CLSH trading in the mid 60’s is dirt cheap.

Get long and enjoy the ride!

Jeff and the IBR Team

 

Contrarian's Mind

Born in Toronto Lived in Nassau,Bahamas - Palm Beach,Florida - Las Vegas,Nevada and now residing in beautiful Barcelona,Spain. I back bright entrepreneurs with big ideas related to Artificial Intelligence, Machine Learning, realtime platforms and price discovery. Make everyday remarkable!

1 Comment

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Subscribe to the IBR blog

Keep up to date with our latest news and recommendations by getting them straight to your inbox!

We will never spam you or give your email address to a third party.